Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

by Elborn, J. Stuart , Taylor-Cousar, Jennifer L , Simard, Christopher , McKee, Charlotte , Moeller, Alexander , Lu, Yimeng , McKone, Edward F , van der Ent, Cornelis K , Ingenito, Edward P , Munck, Anne , Wang, Linda T , Lekstrom-Himes, Julie

in Clinical trials / Cystic fibrosis / Drug dosages / Drug therapy / Mutation / Patients / Pharmaceuticals / Proteins / Quality of life

2017

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

in Clinical trials / Cystic fibrosis / Drug dosages / Drug therapy / Mutation / Patients / Pharmaceuticals / Proteins / Quality of life

2017

Confirm

Do you wish to request the book?

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

in Clinical trials / Cystic fibrosis / Drug dosages / Drug therapy / Mutation / Patients / Pharmaceuticals / Proteins / Quality of life

2017

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

Elborn, J. Stuart,

Taylor-Cousar, Jennifer L,

Simard, Christopher,

McKee, Charlotte,

Moeller, Alexander,

Lu, Yimeng,

McKone, Edward F,

van der Ent, Cornelis K,

Ingenito, Edward P,

Munck, Anne,

Wang, Linda T,

Lekstrom-Himes, Julie

2017

Overview

Patients with homozygous Phe508del cystic fibrosis were assigned to receive combination tezacaftor–ivacaftor or placebo for 24 weeks. The combination resulted in an FEV 1 that was 4 percentage points higher and a pulmonary-exacerbation rate that was 35% lower than with placebo.

Share this book

Add to My Shelf

Publisher

Massachusetts Medical Society

Subject